Related Experiment Video
Updated: Aug 10, 2026
18:01
Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
The effects of pentachlorophenol (PCP) at the toad neuromuscular junction
1Department of Physiological Sciences, Faculty of Biological Sciences and Natural Resources, University of Concepción, Chile.
Summary
Phencyclidine (PCP) blocks evoked transmitter release and increases spontaneous release at the frog neuromuscular junction. 3,4-diaminopyridine (3,4-DAP) counteracts PCP
Area of Science:
- Neuroscience
- Pharmacology
- Muscle Physiology
Background:
- The neuromuscular junction (NMJ) is crucial for muscle contraction.
- Understanding how drugs affect synaptic transmission is vital for pharmacology.
- Phencyclidine (PCP) is known to have complex neurological effects.
Purpose of the Study:
- To investigate the effects of Phencyclidine (PCP) on synaptic transmission at the frog neuromuscular junction.
- To elucidate the mechanism of PCP's action on transmitter release and potential calcium ion (Ca2+) involvement.
Main Methods:
- In vitro study using the sciatic nerve sartorius muscle of the toad Pleurodema-thaul.
- Application of varying concentrations of PCP (0.003-0.1 mM).
- Measurement of evoked transmitter release and spontaneous quantal release, including miniature endplate potential (MEPP) frequency.
Main Results:
- PCP induced a dose- and time-dependent block of evoked transmitter release.
- PCP increased the frequency of spontaneous quantal release and miniature endplate potential (MEPP).
- PCP's effect on MEPP frequency was independent of external Ca2+, suggesting intracellular Ca2+ release.
Conclusions:
- PCP interferes with Ca2+ influx during motor nerve terminal depolarization.
- Intracellular Ca2+ stores, rather than external influx, appear to be the primary source for PCP-induced MEPP frequency increase.
- 3,4-diaminopyridine (3,4-DAP) can counteract PCP's disruptive effects on synaptic transmission.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:29Tetanus
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...